Intervention

recombinant human thrombopoietin

ClinicalTrials.gov intervention label

Clinical trials2

Recruiting0

Common conditions6

Lead sponsors shown2

Clinical trials

2 shown

Clinical Trial on the Prevention of Thrombocytopenia After First-line ChemotherapyNCT01319669 · 2011-02-01

TERMINATED

Peripheral Stem Cell Transplantation in Treating Patients With Breast Cancer or Hematologic CancerNCT00006225 · 1999-11-01

COMPLETED

Common conditions

Breast Cancer1 Carcinoma, Non-Small-Cell Lung1 Leukemia1 Lymphoma1 Multiple Myeloma and Plasma Cell Neoplasm1 Myelodysplastic/Myeloproliferative Diseases1

Leading sponsors

Chinese Society of Lung Cancer1 Northwestern University1

Trial status mix

COMPLETED1

TERMINATED1

Phase mix

PHASE22

PHASE11

PHASE31

How to interpret this record

CureCurrent links normalized diseases, medicines, registry study labels, sponsors and research sites. A link is not the same as a finding of clinical effectiveness. Our research guides explain how to compare studies, decode RxNorm identities, and avoid over-interpreting site and trial counts. See the published database coverage for mapping completeness.

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.